CancerX Moonshot’s Post

📆 Join us on Tues., Aug. 27, at 11 a.m. ET for the public launch of new resources from CancerX’s work to advance equity and reduce financial toxicity in cancer. Patient navigation programming is highly effective in facilitating equitable access to cancer care, reducing financial toxicity, and improving health and quality of life outcomes for cancer patients. However, resource limitations impact the ability of health systems and their partners to scale patient navigation programs to meet comprehensive care needs. These free resources, including an ROI calculator and patient navigation blueprint, will support health systems and patient navigators in developing a business case and digital patient navigation programming strategy – thereby improving access, cost, and health outcomes for more cancer patients. Learn more about how you can use these resources to unlock the promise of digital innovation and minimize disparities in cancer care access and out-of-pocket cost measures associated with cancer. Let’s work together to ensure that health systems can confidently invest in programming that increases equitable access to care and that financial worries do not overshadow cancer patients’ fight for recovery. 🔗 Register now: https://bit.ly/4cuJq3L University of Utah Cancer Support Community Florida Cancer Specialists & Research Institute Epic University of North Carolina System Oracle

When a patient receives a cancer diagnosis, their journey ahead is filled with the unknown. From treatments to countless appointments, every day is consumed by their diagnosis, and the added stress of financial uncertainty should not also weigh on their shoulders. Patient navigation programs effectively enhance equal access to care, diminish financial toxicity, and improve health and quality of life outcomes. However, resource constraints can hinder the widespread use of these programs. Digital solutions can help, but health systems must grapple with return on investment questions as they think about scaling the implementation of patient navigation programs. To address this, CancerX is launching new, free resources, including an ROI calculator and patient navigation blueprint, that will support health systems and patient navigators in developing a business case and digital patient navigation programming strategy – and, thereby, improve access, cost, and health outcomes for more cancer patients. 🗓 Join CancerX and other leaders on Tues., Aug. 27, at 11 a.m. ET to hear more about new resources and how you can use them to advance equity and reduce financial toxicity in cancer. 🔗 Register here: https://bit.ly/4cuJq3L University of Utah Cancer Support Community Florida Cancer Specialists & Research Institute Epic University of North Carolina System Oracle

🏆 Stevie-winner XpertPatient.com is a next-generation, personalized website experience designed to empower those new to a cancer diagnosis with easy-to-understand information and resources. Founded in 2021, site creators aim to help individuals and families devastated by a cancer diagnosis achieve better treatment results. By guiding visitors through a personalized website experience, XpertPatient provides resources, educational material, and community for patients, making a complex and overwhelming life situation easier to navigate and understand. While cancer research and treatments have seen incredible progress over the past decades, unfortunately, little advancement in the approach to patient education has occurred. Through partnerships with patients, caregivers, cancer experts, and health innovators, the website offers curated content through a proven customer experience design. XpertPatient breaks down the complex world of cancer into a personalized education experience for each visitor. Not only is the content curated by cancer type and stage and sub-type (if known), but the platform also offers visitors the opportunity to choose their preferred learning format: easy-to-read text, AI-powered audio over high-resolution medical illustrations, or curated videos from top institutions. XpertPatient won a Bronze Stevie Award for Startup of the Year - Consumer Services Industries in The 2023 American Business Awards®. Read the full blog ➡ https://bit.ly/4aSd6rU

Veris Health receives $1.8M NIH grant for cancer care - MobiHealthNews Veris Health Receives $1.8M NIH Grant for Cancer Care #NIHGrant Veris Health, a leading healthcare IT company, has been awarded a $1.8 million grant from the National Institutes of Health (NIH) to enhance cancer care services. #ResearchInitiative The grant will support a research initiative aimed at improving cancer care delivery through the development of innovative IT solutions. #PatientOutcomes Veris Health's project focuses on enhancing patient outcomes by leveraging technology to streamline care coordination and improve communication among healthcare providers. #DataAnalytics The company plans to utilize advanced data analytics to identify trends and patterns in cancer care delivery, ultimately leading to more personalized and effective treatment plans. #Interoperability Ver ai.mediformatica.com #cancer #health #cancercare #grant #platform #medical #technology #patients #research #diagnostics #digital #digitalhealth #healthit #healthtech #healthcaretechnology @MediFormatica (https://buff.ly/3Yq5Y1z)

Are we all represented in cancer clinical trials? Unfortunately, not yet. An important recent study in JAMA Network Open reveals significant disparities in cancer clinical trial availability in the U.S.: “Social Determinants of Health and the Availability of Cancer Clinical Trials in the United States.” ▪ Socially vulnerable counties are significantly less likely to have cancer clinical trials available compared to less vulnerable counties. ▪ Alarmingly, the disparity in trial availability has worsened over the past 15 years, with the most vulnerable areas having only a fraction of the trials. ▪ The study underscores the need to expand clinical trial opportunities in socially vulnerable communities to ensure equitable cancer care. At Surgo Health, this is a top priority. We are collaborating with several biopharma companies to enhance equity and diversity in clinical trials. https://lnkd.in/emd2T823 #clinicaltrials #healthequity

The Montefiore Cancer Center in The Bronx, NY studied the effectiveness of the MyEleanor app, an AI-based virtual patient navigator, as part of a colorectal cancer screening quality improvement (QI) project. The study explored how AI-driven applications, such as the MyEleanor app, could potentially serve as a complement to a stretched healthcare workforce. The findings of the study showed the potential for AI-driven healthcare applications to provide valuable support within the healthcare sector. The authors conclude that the integration of technology and healthcare, as evidenced by the promising results of the study, presents an opportunity to address critical healthcare needs and improve patient outcomes. The significance of the intersection of technology and healthcare is huge. I think that the study makes a good argument for an EB-2 NIW petition for a computer science professional working on merging technology and healthcare. For more details, you can access the abstract here: https://lnkd.in/eKkSgmY7 #HealthcareResearch #AIinMedicine #NationalInterest #HealthTech

When Sir Francis Bacon said, “Knowledge itself is power,” he probably wasn’t thinking about medical diagnostics at the time. But it has never been more true – the more a patient and their healthcare provider know, and the earlier they know it, the more power they have to make even better healthcare decisions. For most women, regular mammograms are the primary way to provide early detection of #breastcancer – and we should never procrastinate such regular checks. However, for some, the probability of being diagnosed with breast cancer is much higher due to hereditary factors. Historically, women and their physicians did not have the benefit of information available through modern technologies and medical innovations. Today, women can better understand their specific risks and this gift of ‘knowing’ gives us, our moms, wives, sisters, daughters and friends the opportunity for long and healthy lives. At Thermo Fisher Scientific, our Mission – to enable our customers to make the world healthier, cleaner and safer – ensures we take very seriously our role in advancing such innovations though: 🧪Connecting patients to care: According to the American Cancer Society, when caught in the earliest stages, the relative 5-year survival rate for breast cancer is 99%—a staggering success rate for one of the most common cancers in women. Through innovative diagnostic solutions like next-generation sequencing, we’re helping better match patients to the right care. 💊 Supporting powerful research: As testing advances, so does therapeutic discovery. Our technologies are enabling our researchers as they work to discover, develop and deliver new drug and gene therapies to treat cancer.  🤝 Advancing health equity: We know that a crucial part of improving early detection is ensuring patients can access the testing they need. For communities with limited healthcare infrastructure, women are less likely to be diagnosed—and more likely to die—from breast cancer. To reduce these inequities, we’re helping bring solutions to diagnose breast cancer to underserved countries worldwide. #BreastCancerAwarenessMonth is a poignant moment to emphasize the importance of early detection and support improved access to care. I am proud to be part of a team making a difference in cancer care every day, and I encourage you all to take an extra moment this month to educate yourself on breast cancer and how you can be of support. #lifeatthermofisher #missiondriven 

Remote monitoring and data collection are pivotal for decentralized clinical trials (DCTs): - Enhancing Trial Accessibility and Participation: Remote monitoring and data collection eliminate geographical barriers, enabling more patients to participate in clinical trials, especially those who cannot easily access trial centers. This helps expand the sample size, improve data representativeness, and enhance the reliability of trial results. - Reducing Trial Costs and Time: Decentralized clinical trials typically reduce time and cost burdens for both researchers and patients, as patients do not need to frequently visit trial centers. This also reduces the need for physical trial facilities, thus lowering the overall cost of trials. - Improving Real-time and Accurate Data: Remote monitoring and data collection enable real-time collection of patient physiological parameters, symptoms, and treatment responses, providing researchers with more timely and accurate information. This helps in early detection of patient condition changes, thereby improving trial monitoring and management efficiency. - Protecting Patient Privacy and Data Security: Remote monitoring and data collection must strictly adhere to data privacy and security standards to protect patients' personal information and data security. Researchers need to take necessary measures to ensure the security and confidentiality of data to mitigate the risk of data breaches or misuse. - Facing Challenges and Limitations: Such as the requirements for technical devices, patient acceptance of digital technology, data collection consistency, and standardization. Additionally, for certain diseases or specific populations, remote monitoring may not fully replace traditional clinical observation and examination.

Flatiron Health, NCCN Collaborate to Advance Cancer Care with Real-World Data - HIT Consultant #FlatironHealthNCCNCollaboration Flatiron Health and NCCN have joined forces to utilize real-world data to enhance cancer care. This collaboration aims to improve outcomes for cancer patients by leveraging data-driven insights. #RealWorldDataAnalysis The partnership will focus on analyzing real-world data to identify trends, patterns, and best practices in cancer treatment. By analyzing this data, healthcare providers can make more informed decisions and improve patient outcomes. #ClinicalDecisionSupport One of the key goals of the collaboration is to develop clinical decision support tools that can help healthcare providers make evidence-based treatment decisions. These tools will be based on real-world data analysis and will provide personalized treatment recommendations for cancer patients. #EnhancedPatientCare By ai.mediformatica.com #flatiron #cancer #health #data #cancercare #this #realworlddata #research #collaboration #flatironhealth #provider #clinical #digitalhealth #healthit #healthtech #healthcaretechnology @MediFormatica (https://buff.ly/4aRn3ox)

Remote patient monitoring & advantages 💡from saving patients time and improving convenience 💡through giving patients access to doctors when needed via telemedicine visits 💡to being more environmentally friendly due to cutting commute CO2 These are only selected examples. Very interesting to see this data Cristina! #remotetrials #telemedicine #digitalhealth #healthtrends #patientcare